Can doctors tell the difference between meth psychosis and schizophrenia?

NCT ID NCT07184710

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 200 adults in Egypt who have psychosis to compare two conditions: schizophrenia and psychosis caused by methamphetamine use. Researchers will assess symptoms, treatment response, and recovery over three months. The goal is to improve diagnosis and understand how these conditions differ.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better distinguish between methamphetamine-induced psychosis and schizophrenia, leading to more accurate diagnoses and tailored treatments.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve patient care. Results may not apply outside Egypt or to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPARING CLINICAL PROFILE AND PROGNOSIS OF SCHIZOPHRENIA VERSUS METHAMPHETAMINE INDUCED PSYCHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.